ID: ALA1774014

Max Phase: Preclinical

Molecular Formula: C25H30ClN3O2

Molecular Weight: 439.99

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1[C@@H]2CC[C@H]1C[C@@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccccc1)C2

Standard InChI:  InChI=1S/C25H30ClN3O2/c1-29-21-11-12-22(29)16-20(15-21)27-25(31)23(13-18-7-9-19(26)10-8-18)28-24(30)14-17-5-3-2-4-6-17/h2-10,20-23H,11-16H2,1H3,(H,27,31)(H,28,30)/t20-,21+,22-,23-/m1/s1

Standard InChI Key:  WYLPBGBKQSYZQQ-KAOXLYBCSA-N

Associated Targets(Human)

Vasopressin V1a receptor 5412 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver microsomes 16955 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Vasopressin V1a receptor 612 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver microsomes 8692 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 439.99Molecular Weight (Monoisotopic): 439.2027AlogP: 3.35#Rotatable Bonds: 7
Polar Surface Area: 61.44Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.60CX Basic pKa: 9.25CX LogP: 3.30CX LogD: 1.46
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.70Np Likeness Score: -0.70

References

1. Napier S, Wishart G, Arbuckle W, Baker J, Barn D, Bingham M, Brown A, Byford A, Claxton C, Craighead M, Buchanan K, Fielding L, Gibson L, Goodwin R, Goutcher S, Irving N, MacSweeney C, Milne R, Mort C, Presland J, Sloan H, Thomson F, Turnbull Z, Young T..  (2011)  The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists.,  21  (10): [PMID:21458261] [10.1016/j.bmcl.2011.02.096]

Source